In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT

Mi Lan Kang, Sang Gyun Kang, Hu Lin Jiang, Seung Won Shin, Deog Yong Lee, Jeong Min Ahn, Nabin Rayamahji, In Kyu Park, Sung Jae Shin, Chong Su Cho, Han Sang Yoo

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

In vitro immune-stimulating activities of Bordetella bronchiseptica dermonecrotoxin (BBD)-loaded in chitosan microspheres (CMs) were reported with a mouse alveolar macrophage cell line (RAW264.7). Based on the report, in vivo activity of immune-induction was investigated by intranasal administration of the BBD-loaded CMs into mice. BBD was loaded into the CMs prepared by an ionic gelation process with tripolyphosphate. Mice were immunized by direct administration of the BBD-loaded CMs into the nasal cavity. After immunization of the mice, BBD-specific immune responses (IgG and IgA titers) were measured in sera, nasal wash, and saliva by ELISA. BBD-specific IgA titers in the nasal cavity were time- and dose-dependently increased by the administration. Similar phenomena were observed in the analysis of systemic IgA and IgG in sera. However, the antibody in saliva was undetectable by ELISA. These results suggested that direct vaccination via the nasal cavity was effective for targeting nasal-associated lymphoid tissues, and that CMs were an efficient adjuvant in nasal mucosal immunity for atrophic rhinitis vaccine.

Original languageEnglish
Pages (from-to)215-220
Number of pages6
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume63
Issue number2
DOIs
Publication statusPublished - 2006 Jun 1

Fingerprint

Bordetella bronchiseptica
Intranasal Administration
Mucosal Immunity
Chitosan
Microspheres
Nasal Cavity
Nose
Immunoglobulin A
Saliva
Immunoglobulin G
Enzyme-Linked Immunosorbent Assay
Atrophic Rhinitis
Alveolar Epithelial Cells
Alveolar Macrophages
Lymphoid Tissue
Serum
Bordetella dermonecrotic toxin
Immunization
Vaccination
Vaccines

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Pharmaceutical Science

Cite this

Kang, Mi Lan ; Kang, Sang Gyun ; Jiang, Hu Lin ; Shin, Seung Won ; Lee, Deog Yong ; Ahn, Jeong Min ; Rayamahji, Nabin ; Park, In Kyu ; Shin, Sung Jae ; Cho, Chong Su ; Yoo, Han Sang. / In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT. In: European Journal of Pharmaceutics and Biopharmaceutics. 2006 ; Vol. 63, No. 2. pp. 215-220.
@article{e1ecba265bf1401db0ef683987666920,
title = "In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT",
abstract = "In vitro immune-stimulating activities of Bordetella bronchiseptica dermonecrotoxin (BBD)-loaded in chitosan microspheres (CMs) were reported with a mouse alveolar macrophage cell line (RAW264.7). Based on the report, in vivo activity of immune-induction was investigated by intranasal administration of the BBD-loaded CMs into mice. BBD was loaded into the CMs prepared by an ionic gelation process with tripolyphosphate. Mice were immunized by direct administration of the BBD-loaded CMs into the nasal cavity. After immunization of the mice, BBD-specific immune responses (IgG and IgA titers) were measured in sera, nasal wash, and saliva by ELISA. BBD-specific IgA titers in the nasal cavity were time- and dose-dependently increased by the administration. Similar phenomena were observed in the analysis of systemic IgA and IgG in sera. However, the antibody in saliva was undetectable by ELISA. These results suggested that direct vaccination via the nasal cavity was effective for targeting nasal-associated lymphoid tissues, and that CMs were an efficient adjuvant in nasal mucosal immunity for atrophic rhinitis vaccine.",
author = "Kang, {Mi Lan} and Kang, {Sang Gyun} and Jiang, {Hu Lin} and Shin, {Seung Won} and Lee, {Deog Yong} and Ahn, {Jeong Min} and Nabin Rayamahji and Park, {In Kyu} and Shin, {Sung Jae} and Cho, {Chong Su} and Yoo, {Han Sang}",
year = "2006",
month = "6",
day = "1",
doi = "10.1016/j.ejpb.2006.01.010",
language = "English",
volume = "63",
pages = "215--220",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
number = "2",

}

In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT. / Kang, Mi Lan; Kang, Sang Gyun; Jiang, Hu Lin; Shin, Seung Won; Lee, Deog Yong; Ahn, Jeong Min; Rayamahji, Nabin; Park, In Kyu; Shin, Sung Jae; Cho, Chong Su; Yoo, Han Sang.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 63, No. 2, 01.06.2006, p. 215-220.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT

AU - Kang, Mi Lan

AU - Kang, Sang Gyun

AU - Jiang, Hu Lin

AU - Shin, Seung Won

AU - Lee, Deog Yong

AU - Ahn, Jeong Min

AU - Rayamahji, Nabin

AU - Park, In Kyu

AU - Shin, Sung Jae

AU - Cho, Chong Su

AU - Yoo, Han Sang

PY - 2006/6/1

Y1 - 2006/6/1

N2 - In vitro immune-stimulating activities of Bordetella bronchiseptica dermonecrotoxin (BBD)-loaded in chitosan microspheres (CMs) were reported with a mouse alveolar macrophage cell line (RAW264.7). Based on the report, in vivo activity of immune-induction was investigated by intranasal administration of the BBD-loaded CMs into mice. BBD was loaded into the CMs prepared by an ionic gelation process with tripolyphosphate. Mice were immunized by direct administration of the BBD-loaded CMs into the nasal cavity. After immunization of the mice, BBD-specific immune responses (IgG and IgA titers) were measured in sera, nasal wash, and saliva by ELISA. BBD-specific IgA titers in the nasal cavity were time- and dose-dependently increased by the administration. Similar phenomena were observed in the analysis of systemic IgA and IgG in sera. However, the antibody in saliva was undetectable by ELISA. These results suggested that direct vaccination via the nasal cavity was effective for targeting nasal-associated lymphoid tissues, and that CMs were an efficient adjuvant in nasal mucosal immunity for atrophic rhinitis vaccine.

AB - In vitro immune-stimulating activities of Bordetella bronchiseptica dermonecrotoxin (BBD)-loaded in chitosan microspheres (CMs) were reported with a mouse alveolar macrophage cell line (RAW264.7). Based on the report, in vivo activity of immune-induction was investigated by intranasal administration of the BBD-loaded CMs into mice. BBD was loaded into the CMs prepared by an ionic gelation process with tripolyphosphate. Mice were immunized by direct administration of the BBD-loaded CMs into the nasal cavity. After immunization of the mice, BBD-specific immune responses (IgG and IgA titers) were measured in sera, nasal wash, and saliva by ELISA. BBD-specific IgA titers in the nasal cavity were time- and dose-dependently increased by the administration. Similar phenomena were observed in the analysis of systemic IgA and IgG in sera. However, the antibody in saliva was undetectable by ELISA. These results suggested that direct vaccination via the nasal cavity was effective for targeting nasal-associated lymphoid tissues, and that CMs were an efficient adjuvant in nasal mucosal immunity for atrophic rhinitis vaccine.

UR - http://www.scopus.com/inward/record.url?scp=33646841348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646841348&partnerID=8YFLogxK

U2 - 10.1016/j.ejpb.2006.01.010

DO - 10.1016/j.ejpb.2006.01.010

M3 - Article

C2 - 16531027

AN - SCOPUS:33646841348

VL - 63

SP - 215

EP - 220

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

IS - 2

ER -